. 2013 Oct 16;17(3):291–298. doi: 10.1111/1756-185X.12188

Table 2.

Estimated and actual ARI of TB in patients with RA or ankylosing spondylitis treated with anti-TNF-α agents in Japan, Korea, Taiwan and the Philippines

Anti-TNF-α agent	ARI (incidence of TB per 100 000 population with anti-TNF-α agent use)
	Japan		Korea		Taiwan		Philippines
	Estimated	Published²⁰	Estimated	Published⁸^,²¹	Estimated	Published²²	Estimated	Published²³
Etanercept	38	NR	162	0, 0	112	NR	504	NR
Infliximab	391	300	1674	540, 2558	1153	NR	5208	7813
Adalimumab	615	NR	2637	490, NR	1817	9302	8204	NR

ARI, absolute risk increase; TB, tuberculosis; RA, rheumatoid arthritis; TNF-α, tumor necrosis factor alpha; NR, not reported.